AI Article Synopsis
- A specific mutation in the OTOF gene is linked to severe hearing loss, which is studied using mutant mice that mimic this condition.
- Researchers used a base editor technique to correct the mutation in the inner ear of these mice, leading to significant restoration of hearing and otoferlin protein levels.
- The findings suggest that base editing could be a promising approach for treating hereditary deafness in humans.
Article Abstract
A prevalent recessive mutation (c.2485C>T, p.Q829X) within the OTOF gene leads to profound prelingual hearing loss. Here we show that in Otof mice harbouring a mutation (c.2482C>T, p.Q828X) homozygous to human OTOF that faithfully mimics the hearing-loss phenotype, a base editor (consisting of the deaminase ABE7.10max and the Cas9 variant SpCas9-NG) packaged in adeno-associated viruses and injected into the inner ear of the mice via the round-window membrane effectively corrected the pathogenic mutation, with no apparent off-target effects. The treatment restored the levels of the otoferlin protein in 88% of the inner hair cells and stably rescued the auditory function of the mice to near-wild-type levels for over 1.5 years while improving synaptic exocytosis in the inner hair cells. We also show that an adenine base editor that targets the prevalent human OTOF mutation restored hearing in humanized mice to levels comparable to those of the wild-type counterparts. Base editors may be effective for the treatment of hereditary deafness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41551-024-01235-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Letter to the Editor Regarding on the Manuscript "Characteristics of Posterior Ethmoidal Artery and its Relationship with Anterior Ethmoidal Artery and Skull Base on CT Scan".
Medeni Med J
December 2024
Al-Kindy College of Medicine, University of Baghdad, Department of Paediatrics, Baghdad, Iraq.
In vivo adenine base editing ameliorates Rho-associated autosomal dominant retinitis pigmentosa.
J Genet Genomics
December 2024
MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510275, China; Key Laboratory of Reproductive Medicine of Guangdong Province, the First Affiliated Hospital and School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510275, China. Electronic address:
Mutations in the Rhodopsin (RHO) gene are the main cause of autosomal dominant retinitis pigmentosa (adRP), 84% of which are pathogenic gain-of-function point mutations. Treatment strategies for adRP typically involve silencing or ablating the pathogenic allele, while normal RHO protein replacement has no meaningful therapeutic benefit. Here, we present an adenine base editor (ABE)-mediated therapeutic approach for adRP caused by RHO point mutations in vivo.
View Article and Find Full Text PDFThe impact of Cochrane Reviews that apply network meta-analysis in clinical guidelines: A systematic review.
PLoS One
December 2024
Department for Health Data Science, University of Liverpool, Liverpool, United Kingdom.
Background: Systematic reviews, such as those prepared by Cochrane, are the strongest evidence on which to base recommendations in clinical guidelines. Network meta-analysis (NMA) can be used to combine the results of studies to compare multiple treatments, which is advantageous over pair-wise meta-analysis (PW-MA) that compares two treatments. We aimed to summarise which, when, where, who, and why Cochrane Reviews that applied NMA were cited in guidelines; and to compare the citation of NMA reviews in guidelines with PW-MA reviews.
View Article and Find Full Text PDFBuilding the first base editors.
Nat Chem Biol
January 2025
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!